Transforming growth factor-β and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing

Journal of Surgical Research

Volumn 61, Issue 1, 1996, Pages 113-119

  Bitar, Milad S ^a   Labbad, Ziad N ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b TEMPLE UNIVERSITY SCHOOL OF PODIATRIC MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETES MELLITUS; EXTRACELLULAR MATRIX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN INCISION; SKIN STIMULATION; STREPTOZOCIN DIABETES; TENSILE STRENGTH; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 0030059185     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1996.0090     Document Type: Article

References (38)

1. Goodson, W. H., and Hunt, T. K. Studies of wound healing in experimental diabetes. J. Surg. Res. 22: 221, 1977.
2. Goodson, W. H., and Hunt, T. K. Wound healing and the diabetic patient. Surg. Gyn. Obstet. 149: 600, 1979.
3. Rosenthal, S., Lerner, B., DiBiase, F., and Enquist, I. F. Relation of strength to composition in diabetic wounds. Surg. Gynecol. Obstet. 115: 437, 1962.
4. Prakash, A., Pandit, P. N., and Sharma, L. K. Studies in wound healing in experimental diabetes. Inter. Surg. 59: 75, 1974.
5. Yue, D. K., Swanson, B., McLennan, S., Marsh, M., et al. Abnormalities of granulation tissue and collagen formation in experimental diabetes, uremia and malnutrition. Diab. Med. 3: 221, 1986.
6. Andreassen, T. T., and Oxlund, H. The influence of experimental diabetes and insulin treatments on the biomechanical properties of rat skin incisional wounds. Acta Chair. Scand. 153: 405, 1987.
7. Grant, M., Jerdan, J., and Merimee, T. J. Insulin-like growth factor-1 modulates endothelial chemotaxis. J. Clin. Endocrinol. Metab. 65: 370, 1987.
8. Assoian, R. K., Grontendorst, G. R., Miller, D. M., and Sporn, M. B. Cellular transformation by coordinated action of three growth factors from human platelets. Nature 308: 804, 1984.
9. Postlethwaite, A. E., Keski-oja, J., Moses, H. L., and Kang, H. A. Stimulation of chemotactic migration of human fibroblasts by transforming growth factor beta. J. Exp. Med. 165: 251, 1987.
10. Knighton, D. R., Fiegel, V. D., Austin, L. L., Ciresi, K. F., and Butler, D. L. Classification and treatment of chronic nonhealing wounds. Ann. Surg. 204: 322, 1986.
11. Brown, G. L., Curtsinger, L. J., White, M., et al. Acceleration of tensile strength of incisions treated with EGF and TGF-beta. Ann. Surg. 208: 788, 1988.
12. Roberts, A. B., Sporn, M. B., Assovan, R. K., et al. Transforming growth factor beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation. Proc. Natl. Acad. Sci. USA 83: 4167, 1986.
13. Knighton, D. R., Ciresi, K., Fiegel, V. D., Schumerth, S., Butler, E., and Cerra, F. Stimulation of repair in chronic nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg. Gynecol. Obstet. 170: 56, 1990.
14. Pierce, G. F., Mustoe, T. A., Lingelbach, J., Masakowski, V. R., Gramates, P., and Deuel, T. F. Transforming growth factor beta reverses the glucocorticoid induced wound healing deficit in rats: possible regulation in macrophages by PDGF. Proc. Natl. Acad. Sci. USA 86: 2229, 1989.
15. Grotendorst, G. R., Martin, G. R., Pencev, D., Sodek, J., and Harvey, A. K. Stimulation of granulation tissue formation by platelet derived growth factor in normal and diabetic rats. J. Clin. Invest. 76: 2323, 1985.
16. Greenhalgh, D. G., Sprugel, K. H., Murray, M. J., and Ross, R. PDGF and EGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 136: 1235, 1990.
17. Holloway, G. A., Steed, D. L., DeMarco, M. J., et al. A randomized, controlled, multicenter, dose response trial of activated platelet supernatant, topical CT-102 in chronic, non healing diabetic wounds. Wounds 5: 198, 1993.
18. Rerup, C. C. Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22: 485, 1970.
19. Shein, P. S., Cooney, D. A., McMenamin, M. G., and Anderson, T. Streptozotocin diabetes: further studies on the mechanism of depression of nicotinamide adenine dinucleotide concentrations in mouse pancreatic islets and liver. Biochem. Pharmacol. 22: 2625, 1973.
20. Mossman, B. T., Ireland, C. M., Filipack, M., LeDoux, S., and Wilson, G. L. Comparative interactions of streptozotocin and chlorozotocin with DNA of an insulin secreting cell line (RINR). Diabetologia 29: 186, 1986.
21. Behr, S. R., and Kraemer, F. B. Insulin deficiency decreases lipoprotein lipase secretion by immune macrophages. Diabetes 37: 1076, 1989.
22. Engesaeter, L. B., and Skar, A. G. Effects of tetracycline on the mechanical properties of bone and skin in young rats. Acta Orthop. Scand. 49: 529, 1978.
23. Levenson, S. M., Geever, E. F., Crowley, L. V., Oates, J. F., Berard, C. W., and Rosen, H. The healing of rat skin wounds. Ann. Surg. 161: 293, 1965.
24. Woessner, J. F., Jr. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino-acid. Arch. Biochem. Biophys. 93: 440, 1961.
25. Tucker, R. F., Shipley, G. D., Moses, H. L., and Holley, R. W. Growth inhibitor from BSC-1 cells closely related to platelet type beta transforming growth factor. Science 226: 705, 1984.
26. Like, B., and Massague, J. The antiproliferative effect of type beta transforming growth factor occurs at a level digetal from receptors for growth-activating factor. J. Biochem. 261: 13426, 1986.
27. Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., and Binoux, M. Analysis of serum insulin like growth factor binding proteins using western blotting: Use of method for titration of binding proteins and competitive binding studies. Anal. Biochem. 154: 136, 1986.
28. Heussen, C., and Dowdle, E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196, 1980.
29. Thompson, E. W., Brunner, N., Torri, J., et al. The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin. Exp. Metastasis 11: 15, 1993.
30. Feteris, W. A. A serum glucose method without protein precipitation. Am. J. Med. Technol. 31: 17, 1965.
31. Yue, D. K., McLennan, S., Marsh, M., Mai, Y. W., Spaliviero, J., Delbridge, L., Reeve, T., and Turtle, J. R. Effects of experimental diabetes, uremia and malnutrition on wound healing. Diabetes 36: 295, 1987.
32. VilJanto, J. The biochemical basis of tensile strength in wound healing-an experimental study with viscose cellulose sponges in rats. Acta Chirug. Scand. 333(Suppl): 1, 1964.
33. Whal, S. M., Hunt, D. E., Wakefield, L. M., et al. Transforming growth factor type beta induces monocytes chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84: 5788, 1987.
34. Grant, M., Jerdan, J., and Merimee, T. J. Insulin-like growth factor-1 modulates endothelial cell chemotaxis. J. Clin. Endocrinol. Metab. 65: 370, 1987.
35. Massague, J. The transforming growth factor-beta family. Annu. Rev. Cell. Biol. 6: 597, 1990.
36. Suh, D. Y., Hunt, T. K., and Spencer, E. M. Insulin like growth factor-I reverses the impairment of wound healing induced by corticosteroids in rats. Endocrinology 131: 2399, 1992.
37. Fahey, T. J., Sadaty, A., Jones, W. G., et al. Diabetes impairs the late inflammatory response to wound healing. J. Surg. Res. 50: 308, 1991.
38. Hennessey, P. J., Black, T. C., and Andrassy, R. J. EGF increases short-term type I collagen accumulation during wound healing in diabetic rats. J. Ped. Surg. 25: 893, 1990.